| 臺大學術典藏 |
2022-09-20T06:48:29Z |
Diagnosis and Treatment for embolic stroke of undetermined source: Consensus statement from the Taiwan stroke society and Taiwan society of cardiology
|
Tsai L.-K.; Lee I.-H.; Chen Y.-L.; Chao T.-F.; Chen Y.-W.; Po H.L.; Lien L.-M.; Chu P.-H.; Huang W.-C.; Lin T.-H.; Lin M.-T.; Jeng J.-S.; HWANG, JUEY-JEN |
| 臺大學術典藏 |
2022-09-06T01:29:31Z |
Effectiveness of Standard-Dose vs. Low-Dose Alteplase for Acute Ischemic Stroke Within 3–4.5 h
|
Chen C.-H.; Tang S.-C.; Chen Y.-W.; Chen C.-H.; Tsai L.-K.; Sung S.-F.; Lin H.-J.; Huang H.-Y.; Po H.L.; Sun Y.; Chen P.-L.; Chan L.; Wei C.-Y.; Lee J.-T.; Hsieh C.-Y.; Lin Y.-Y.; Lien L.-M.; JIANN-SHING JENG |
| 臺大學術典藏 |
2022-09-06T01:29:27Z |
2021 Taiwan Stroke Society Guidelines of blood pressure control for ischemic stroke prevention
|
Chi N.-F.; Chung C.-P.; Cheng H.-M.; Liu C.-H.; Lin C.-J.; Hsu L.-C.; Tang S.-C.; Lee J.-T.; Po H.L.; JIANN-SHING JENG; Wang T.-D.; Lee I.-H.; Taiwan Stroke Society Guideline Consensus Group |
| 臺大學術典藏 |
2022-01-25T03:25:12Z |
Hyperglycemia combined Helicobacter pylori infection increases risk of synchronous colorectal adenoma and carotid artery plaque
|
Hu K.-C.; Wu M.-S.; Chu C.-H.; Wang H.-Y.; Lin S.-C.; Po H.L.; Bair M.-J.; Liu C.-C.; Su T.-H.; CHI-LING CHEN; Liu C.-J.; Shih S.-C. |
| 臺大學術典藏 |
2022-01-24T09:31:26Z |
Hyperglycemia combined Helicobacter pylori infection increases risk of synchronous colorectal adenoma and carotid artery plaque
|
Hu K.-C.; Wu M.-S.; Chu C.-H.; Wang H.-Y.; Lin S.-C.; Po H.L.; Bair M.-J.; Liu C.-C.; Su T.-H.; Chen C.-L.; CHUN-JEN LIU; Shih S.-C. |
| 國立成功大學 |
2022 |
Effectiveness of Standard-Dose vs. Low-Dose Alteplase for Acute Ischemic Stroke Within 3–4.5 h
|
Chen, Chen C.-H.;Tang, S.-C.;Chen, Y.-W.;Chen, Chen C.-H.;Tsai, L.-K.;Sung, Sung S.-F.;Lin, H.-J.;Huang, Huang H.-Y.;Po, H.L.;Sun, Y.;Chen, P.-L.;Chan, L.;Wei, C.-Y.;Lee, J.-T.;Hsieh, C.-Y.;Lin, Y.-Y.;Lien, Lien L.-M.;Jeng, Jeng J.-S. |
| 臺大學術典藏 |
2021-12-22T03:54:15Z |
The efficacy and safety of cilostazol in ischemic stroke patients with peripheral arterial disease (SPAD): Protocol of a randomized, double-blind, placebo-controlled multicenter trial
|
JIANN-SHING JENG; Sun Y.; Lee J.-T.; Lin R.-T.; Chen C.-H.; Po H.L.; Lin H.-J.; Liu C.-H.; Sun M.-H.; Sun M.-C.; Chern C.-M.; Lien L.-M.; Chiu H.-C.; Hu H.-H.; Chiou H.-Y.; Chen S.-T.; Ma H.; Hsu C.Y.; SPAD Study Investigators |
| 臺大學術典藏 |
2021-12-22T03:53:49Z |
Intravenous thrombolysis administration 3–4.5 h after acute ischemic stroke: A retrospective, multicenter study
|
Chen Y.-W.; Sung S.-F.; Chen C.-H.; Tang S.-C.; Tsai L.-K.; Lin H.-J.; Huang H.-Y.; Po H.L.; Sun Y.; Chen P.-L.; Chan L.; Wei C.-Y.; Lee J.-T.; Hsieh C.-Y.; Lin Y.-Y.; Yeh S.-J.; Lien L.-M.; JIANN-SHING JENG |
| 臺大學術典藏 |
2021-12-22T03:53:39Z |
Diagnosis and Treatment for embolic stroke of undetermined source: Consensus statement from the Taiwan stroke society and Taiwan society of cardiology
|
Tsai L.-K.; Lee I.-H.; Chen Y.-L.; Chao T.-F.; Chen Y.-W.; Po H.L.; Lien L.-M.; Chu P.-H.; Huang W.-C.; Lin T.-H.; Lin M.-T.; JIANN-SHING JENG; Hwang J.-J. |
| 臺大學術典藏 |
2021-11-26T05:56:30Z |
Intravenous thrombolysis administration 3–4.5 h after acute ischemic stroke: A retrospective, multicenter study
|
Chen Y.-W.; Sung S.-F.; Chen C.-H.; Tang S.-C.; LI-KAI TSAI; Lin H.-J.; Huang H.-Y.; Po H.L.; Sun Y.; Chen P.-L.; Chan L.; Wei C.-Y.; Lee J.-T.; Hsieh C.-Y.; Lin Y.-Y.; Yeh S.-J.; Lien L.-M.; Jeng J.-S. |
